Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 in Amyotrophic Lateral Sclerosis Psychedelics Investing
Medtronic Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Announces 9% Dividend Increase Medical Device Investing
Knight Therapeutics Announces Closing of Previously Announced Acquisition and Exclusive License to Exelon® in Canada and Latin America Medical Device Investing
Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids Pharmaceutical Investing
EBON, DOX & SHRMF Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen Medical Device Investing
Cloud DX and Maxwell Telecare Partner to Bring Round-the-Clock Virtual Care and Vitals Monitoring to Residents of US Long-Term Care Facilities Life Science Investing
AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society Annual Scientific Meeting Biotech Investing
Avisa Diagnostics Retains Venture Liquidity Providers Inc. for Market-Making Services Medical Device Investing
Bristol Myers Squibb to Take Part in Bernstein's 37th Annual Strategic Decisions Conference Biotech Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
